Ascendis Pharma (Brazil) Investor Sentiment

A1SN34 Stock  BRL 53.35  1.65  3.00%   
About 62% of Ascendis Pharma's investor base is looking to short. The analysis of current outlook of investing in Ascendis Pharma AS suggests that many traders are alarmed regarding Ascendis Pharma's prospects. The current market sentiment, together with Ascendis Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Ascendis Pharma AS stock news signals to limit their universe of possible portfolio assets.
  
over two months ago at news.google.com         
Fred Alger Management LLC Grows Stock Holdings in Ascendis Pharma AS - MarketBeat
Google News at Macroaxis
over two months ago at news.google.com         
BofA sustains Buy on Ascendis, raises stock target on treatment result - Investing.com
Google News at Macroaxis
over two months ago at news.google.com         
Ascendis Pharma AS Announces Pricing of Public Offering of ADSs - StockTitan
Google News at Macroaxis
over two months ago at news.google.com         
Ascendis Pharma Moves 17.1 percent Higher Will This Strength Last - Yahoo Finance
Google News at Macroaxis
over two months ago at news.google.com         
Why This Small Biotech Is Hammering BioMarin Today - Investors Business Daily
Google News at Macroaxis
over two months ago at news.google.com         
Ascendis Pharma AS Among Hedge Funds Top Biotech Stock Picks - Yahoo Finance
Google News at Macroaxis
over three months ago at news.google.com         
Biotech Makes A Bearish Move On Drug-Pricing Fiasco - Investors Business Daily
Google News at Macroaxis
over three months ago at news.google.com         
Ascendis Pharma Posts Loss in First Half of 2024 - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
Ascendis Pharma Surges 8.7 percent Is This an Indication of Further Gains - MSN
Google News at Macroaxis
over three months ago at news.google.com         
Ascendis Pharma AS Downgraded to Sell at StockNews.com - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Ascendis Pharma AS Lowered to Sell at StockNews.com - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
Ascendis Pharma wins FDA approval for first and only treatment for rare disease - MarketWatch
Google News at Macroaxis
over three months ago at news.google.com         
Bessemer Group Inc. Purchases 332 Shares of Ascendis Pharma AS - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Ascendis Pharma AS Share Price Could Signal Some Risk - Simply Wall St
Google News at Macroaxis
over three months ago at news.google.com         
Ascendis Pharma AS Given Consensus Recommendation of Moderate Buy by Analysts - Defense World
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Ascendis Pharma that are available to investors today. That information is available publicly through Ascendis media outlets and privately through word of mouth or via Ascendis internal channels. However, regardless of the origin, that massive amount of Ascendis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ascendis Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ascendis Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ascendis Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ascendis Pharma alpha.

Ascendis Pharma Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Ascendis Stock analysis

When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes